A randomized double blind controlled trial of the efficacy and safety of Polycap (Quintapill) versus its components in subjects with at least one additional cardiovascular risk factor

Trial Profile

A randomized double blind controlled trial of the efficacy and safety of Polycap (Quintapill) versus its components in subjects with at least one additional cardiovascular risk factor

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Hydrochlorothiazide/atenolol/ramipril/simvastatin/aspirin (Primary) ; Aspirin; Atenolol; Hydrochlorothiazide; Ramipril; Simvastatin
  • Indications Cardiovascular disorders; Embolism and thrombosis
  • Focus Therapeutic Use
  • Acronyms TIPS
  • Most Recent Events

    • 22 Sep 2010 Actual end date (1 Oct 2008) added as reported by ClinicalTrials.gov.
    • 03 Feb 2010 New source identified and integrated (Clinical Trials Registry - India, CTRI2007-091-000015).
    • 16 Jun 2009 Hydrochlorothiazide/atenolol/ramipril/simvastatin/aspirin added as a drug treatment
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top